Response to Re: 'Neoadjuvant chemotherapy for advanced ovarian cancer. Who really benefits?'
Aust N Z J Obstet Gynaecol
.
2018 Dec;58(6):E26-E27.
doi: 10.1111/ajo.12925.
Author
Neville F Hacker
1
Affiliation
1
Gynaecological Cancer Centre Royal Hospital for Women Randwick, Australia.
PMID:
30536513
DOI:
10.1111/ajo.12925
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Ovarian Epithelial*
Chemotherapy, Adjuvant
Cytoreduction Surgical Procedures
Female
Humans
Neoadjuvant Therapy
Ovarian Neoplasms*